Generalized Anxiety Disorder (GAD) Market

Jan 08, 2021

10 likes | 14 Views

Generalized Anxiety Disorder (GAD) Market Generalized Anxiety Disorder (GAD) is characterized by persistent and exaggerated anxiety and worry about everyday life events with no apparent reasons for worry. As per the Delveinsight, in 2017, the total 12-Month prevalent cases of Generalized Anxiety Disorder (GAD) in 7MM was 16,606,987. The Generalized Anxiety Disorder (GAD) market size in the 7MM was USD 3,164 million in 2017. Increasing awareness and prevalence and improved diagnostic criteria are the key drivers for the Generalized Anxiety Disorder (GAD) Market. The key companies in the Generalized Anxiety Disorder (GAD) Market include Bionomics, Pherin Pharmaceuticals, VistaGen Therapeutics, Shire, and BioHaven Pharmaceuticals. Source: Generalized Anxiety Disorder (GAD) Treatment Market

DelveInsight

Download Presentation

Generalized Anxiety Disorder (GAD) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D